Compounded non-FDA–approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey

por Pinkerton, JoAnn V., Constantine, Ginger D.
Publicado 2016

SAT-LB003 Nonsmokers Benefit from Lower Doses of an Estradiol/Progesterone Combination: Results of the REPLENISH Trial

por Constantine, Ginger, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado 2019

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program

por Constantine, Ginger D., Goldstein, Steven R., Archer, David F.
Publicado 2015

Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors

por Constantine, Ginger D., Kessler, Grant, Graham, Shelli, Goldstein, Steven R.
Publicado 2019

Systemic estradiol levels with low-dose vaginal estrogens

por Santen, Richard J., Mirkin, Sebastian, Bernick, Brian, Constantine, Ginger D.
Publicado 2019

Improvement in sleep outcomes with a 17β-estradiol–progesterone oral capsule (TX-001HR) for postmenopausal women

por Kagan, Risa, Constantine, Ginger, Kaunitz, Andrew M., Bernick, Brian, Mirkin, Sebastian
Publicado 2018

SAT-001 Clinically Meaningful Effects of E2/P4 Oral Capsule in Treating Vasomotor Symptoms

por Constantine, Ginger, Graham, Shelli, Revicki, Dennis A, Kagan, Risa, Mirkin, Sebastian
Publicado 2020

SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms

por Constantine, Ginger, Goldstein, Steven, Pickar, James, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado 2019

SAT-237 Combined Bioidentical Estradiol and Progesterone Capsules Improved Quality of Sleep in Postmenopausal Women with Vasomotor Symptoms

por Santoro, Nanette, Constantine, Ginger, Kagan, Risa, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado 2019

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

por Constantine, Ginger D., Archer, David F., Graham, Shelli, Bernick, Brian A., Mirkin, Sebastian
Publicado 2016

SAT-021 Effects of E2/P4 Oral Capsules on Bone Turnover in Women with Vasomotor Symptoms

por Constantine, Ginger, McClung, Michael R, Kagan, Risa, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado 2020

17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial

por Kaunitz, Andrew M., Bitner, Diana, Constantine, Ginger D., Bernick, Brian, Graham, Shelli, Mirkin, Sebastian
Publicado 2020

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms

por McClung, Michael R., Kagan, Risa, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian, Constantine, Ginger
Publicado 2022

Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence

por Archer, David F., Carr, Bruce R., Pinkerton, JoAnn V., Taylor, Hugh S., Constantine, Ginger D.
Publicado 2015

Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone

por Mirkin, Sebastian, Graham, Shelli, Revicki, Dennis A., Bender, Randall H., Bernick, Brian, Constantine, Ginger D.
Publicado 2019

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

por Constantine, Ginger D., Graham, Shelli, Lapane, Kate, Ohleth, Kathleen, Bernick, Brian, Liu, James, Mirkin, Sebastian
Publicado 2019

Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries

por Constantine, Ginger D, Graham, Shelli, Clerinx, Cathy, Bernick, Brian A, Krassan, Mitchell, Mirkin, Sebastian, Currie, Heather
Publicado 2016

Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmen...

por Constantine, Ginger D., Bouchard, Celine, Pickar, James H., Archer, David F., Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado 2017

Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial

por Simon, James A., Archer, David F., Kagan, Risa, Bernick, Brian, Graham, Shelli, Constantine, Ginger D., Mirkin, Sebastian
Publicado 2017

Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms

por Constantine, Ginger D., Revicki, Dennis A., Kagan, Risa, Simon, James A., Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado 2019